Category: Molecular Diagnostics
Global Molecular Diagnostics
-
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030
... driven by the increasing emphasis on personalized medicine. Rising research & development investments in the pharmaceutical and biotechnology industries also contribute to the expansion of single-cell analysis. Additionally, factors such as growth in stem cell ... Read More
-
Global in Vitro Diagnostics Contract Manufacturing Market 2025-2029
... period. The report on the in vitro diagnostics (IVD) contract manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Veterinary Molecular Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
2025 Global: Isothermal Nucleic Acid Amplification Technology (Inaat) Market - Innovative Markets Forecast (2031) report
... the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2020 to 2031 using regression analysis in our modeling. and Perry/Hope is ... Read More
-
Global Genetic Testing Market 2025-2029
... provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest ... Read More
-
Oncology Molecular Diagnostics Global Market Report 2025
... market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective ... Read More
-
Cancer Diagnostics Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Nucleic Acid Based Gene Therapy Global Market Report 2025
... acid based gene therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Microfluidic Devices Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Aptamers
... 15.7% over the analysis period 2024-2030. DNA Aptamers, one of the segments analyzed in the report, is expected to record a 15.7% CAGR and reach US$227.5 Million by the end of the analysis period. Growth ... Read More
-
Isothermal Nucleic Acid Amplification Technology (INAAT)
... reach US$6.7 Billion by 2030, growing at a CAGR of 10.2% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 10.0% CAGR and reach US$4.6 ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Single Nucleotide Polymorphism (SNP) Chips, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$1.6 ... Read More
-
Molecular Diagnostics
... CAGR of 9.2% over the analysis period 2024-2030. Reagents & Kits, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$16.0 Billion by the end of the ... Read More
-
Nucleic Acid Testing
... at a CAGR of 4.5% over the analysis period 2024-2030. Nucleic Acid Test Kits, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$3.7 Billion by the ... Read More
-
Nucleic Acid Labeling
... at a CAGR of 7.5% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Oncology Molecular Diagnostics
... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Critical Care Diagnostics
... at a CAGR of 5.9% over the analysis period 2024-2030. Immunoproteins, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$713.5 Million by the end of the ... Read More
-
E. Coli Testing
... at a CAGR of 5.0% over the analysis period 2024-2030. Environmental Testing, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$2.0 Billion by the end of ... Read More
-
Western Blotting
... CAGR of 5.3% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.1 Billion by the end of the analysis period. ... Read More
-
Microfluidic Device Systems
... at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro diagnostics, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end of ... Read More
-
Veterinary Molecular Diagnostics
... at a CAGR of 7.5% over the analysis period 2024-2030. Instruments & Software, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$342.8 Million by the end ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
DNA Probes-Based Diagnostics
... at a CAGR of 9.4% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$20.4 Billion by the end of ... Read More
-
Point of Care (POC) Molecular Diagnostics
... reach US$8.8 Billion by 2030, growing at a CAGR of 12.9% over the analysis period 2024-2030. Infectious Diseases, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach ... Read More
-
Genetic Testing
... CAGR of 9.9% over the analysis period 2024-2030. Cancer, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$13.6 Billion by the end of the analysis period. ... Read More
Research Assistance
